My emphasis is on reorganization and restructure. I plan and execute these regularly.
If you’re still working on this, let me know and I’ll give you clarity on treatment.
This is not a surplus strip (section 55), but a simple redemption (section 84). Firstly, corporations can only redeem specified classes of shares given there is enough safe income to do so (for purposes of Section 84, redemptions are deemed dividends). Otherwise, a corporation can redeem a specified class of shares on liquation of the company above it’s safe income.
You CANNOT have a company simply subscribe to a specified share class and then have the counter-party redeem that share class, you are subjecting yourself to GAAR attributions and CRA may, and will, disallow the redemption completely.
However, for knowledge purposes, assuming this was done in a more correct manner, you would have the redemption as recorded on S3 of the company B as a regular dividend (make sure to account for the applicable part 4 taxes if necessary), with the corresponding entry on gifi 100 affecting RE. For accounting purposes, you record the Dr. ($799,999) as an equity distribution account (dividend / redemption of shares) on your RE lead sheet and close it out in the subsequent year as a equity.
For company A, you record the redemption as a return on your ACB when the cash is paid. If the company returned the full $800k, you wouldn’t realize a loss. This goes to your schedule 3 and deductible pursuant to subsection 112. you don’t need to record it as dividend income for accounting purposes, but you need to record it as a deemed dividend for tax purposes.
Company A (bookkeeping entry):
Dr. Cash or due form Company B - $800,000
Cr. Investment in Company B - $800,000
Company B (Accounting entry):
Dr. Share capital - $1
Dr. Redemption of shares - $799,999
Dr. Cash or due to Company A - $800,000
Note that new legislation was introduced for 2024 that replaces the surplus scheme with a “test of economic substance”, essentially disallowing a surplus strip where the transaction has no application of economic benefit to the company or individual shareholders primary activities.